Former Teva Employee Blames Firing on Helping Feds With Bribery Probe
Earlier this year, Teva Pharmaceutical disclosed an internal investigation found business practices that were “likely” violations of the Foreign Corrupt Practices Act. The drug maker began its probe after receiving subpoenas and other requests for information related to foreign bribery from the U.S. Securities and Exchange Commission and the U.S. Department of Justice Department in 2012 (see page 6).